Literature DB >> 21076414

Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells.

Jonathan W Astin1, Jennifer Batson, Shereen Kadir, Jessica Charlet, Raj A Persad, David Gillatt, Jon D Oxley, Catherine D Nobes.   

Abstract

Metastatic cancer cells typically fail to halt migration on contact with non-cancer cells. This invasiveness is in contrast to normal mesenchymal cells that retract on contact with another cell. Why cancer cells are defective in contact inhibition of locomotion is not understood. Here, we analyse the dynamics of prostate cancer cell lines co-cultured with fibroblasts, and demonstrate that a combinatorial code of Eph receptor activation dictates whether cell migration will be contact inhibited. The unimpeded migration of metastatic PC-3 cells towards fibroblasts is dependent on activation of EphB3 and EphB4 by ephrin-B2, which we show activates Cdc42 and cell migration. Knockdown of EphB3 and EphB4 restores contact inhibition of locomotion to PC-3 cells. Conversely, homotypic collisions between two cancer cells results in contact inhibition of locomotion, mediated by EphA-Rho-Rho kinase (ROCK) signalling. Thus, the migration of cancer cells can switch from restrained to invasive, depending on the Eph-receptor profile of the cancer cell and the reciprocal ephrin ligands expressed by neighbouring cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076414     DOI: 10.1038/ncb2122

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  46 in total

Review 1.  Mechanisms and functions of Eph and ephrin signalling.

Authors:  Klas Kullander; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

2.  Tumor cell migration in three dimensions.

Authors:  Steven Hooper; John F Marshall; Erik Sahai
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Cell locomotion and contact inhibition of normal and neoplastic rat cells.

Authors:  P Veselý; R A Weiss
Journal:  Int J Cancer       Date:  1973-01-15       Impact factor: 7.396

4.  Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice.

Authors:  D D Mickey; K R Stone; H Wunderli; G H Mickey; D F Paulson
Journal:  Prog Clin Biol Res       Date:  1980

Review 5.  Contact inhibition in tissue culture.

Authors:  M Abercrombie
Journal:  In Vitro       Date:  1970 Sep-Oct

6.  EphB4 expression and biological significance in prostate cancer.

Authors:  Guangbin Xia; S Ram Kumar; Rizwan Masood; Sutao Zhu; Ramchandra Reddy; Valery Krasnoperov; David I Quinn; Susan M Henshall; Robert L Sutherland; Jacek K Pinski; Siamak Daneshmand; Maurizio Buscarini; John P Stein; Chen Zhong; Daniel Broek; Pradip Roy-Burman; Parkash S Gill
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

7.  Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling.

Authors:  Takuji Iwasato; Hironori Katoh; Hiroshi Nishimaru; Yukio Ishikawa; Haruhisa Inoue; Yoshikazu M Saito; Reiko Ando; Mizuho Iwama; Ryosuke Takahashi; Manabu Negishi; Shigeyoshi Itohara
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

8.  Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.

Authors:  Cedric Gaggioli; Steven Hooper; Cristina Hidalgo-Carcedo; Robert Grosse; John F Marshall; Kevin Harrington; Erik Sahai
Journal:  Nat Cell Biol       Date:  2007-11-25       Impact factor: 28.824

9.  Rho-kinase phosphorylates PAR-3 and disrupts PAR complex formation.

Authors:  Masanori Nakayama; Takaaki M Goto; Masayuki Sugimoto; Takashi Nishimura; Takafumi Shinagawa; Sigeo Ohno; Mutsuki Amano; Kozo Kaibuchi
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

10.  Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase.

Authors:  Nadia Munarini; Richard Jäger; Susanne Abderhalden; Gisela Zuercher; Valeria Rohrbach; Saemi Loercher; Brigitte Pfanner-Meyer; Anne-Catherine Andres; Andrew Ziemiecki
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

View more
  122 in total

1.  Cancer cells exploit the Eph-ephrin system to promote invasion and metastasis: tales of unwitting partners.

Authors:  Bingcheng Wang
Journal:  Sci Signal       Date:  2011-05-31       Impact factor: 8.192

Review 2.  Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis.

Authors:  Eduard Batlle; David G Wilkinson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

Review 3.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

4.  EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex.

Authors:  Guo Li; Xiao-Dan Ji; Hong Gao; Jiang-Sha Zhao; Jun-Feng Xu; Zhi-Jian Sun; Yue-Zhen Deng; Shuo Shi; Yu-Xiong Feng; Yin-Qiu Zhu; Tao Wang; Jing-Jing Li; Dong Xie
Journal:  Nat Commun       Date:  2012-02-07       Impact factor: 14.919

Review 5.  Developing Cures: Targeting Ontogenesis in Cancer.

Authors:  Victor T G Lin; Hawley C Pruitt; Rajeev S Samant; Lalita A Shevde
Journal:  Trends Cancer       Date:  2017-01-27

Review 6.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

7.  Complementary expression and repulsive signaling suggest that EphB2 and ephrin-B1 are possibly involved in epithelial boundary formation at the squamocolumnar junction in the rodent stomach.

Authors:  Kazushige Ogawa; Noritaka Saeki; Yasutaka Igura; Yuta Hayashi
Journal:  Histochem Cell Biol       Date:  2013-07-24       Impact factor: 4.304

Review 8.  Eph receptor signaling and ephrins.

Authors:  Erika M Lisabeth; Giulia Falivelli; Elena B Pasquale
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

9.  Design, synthesis and biological evaluation of tryptamine salicylic acid derivatives as potential antitumor agents.

Authors:  Runde Xiong; Dongxiu He; Xiangping Deng; Juan Liu; Xiaoyong Lei; Zhizhong Xie; Xuan Cao; Yanming Chen; Junmei Peng; Guotao Tang
Journal:  Medchemcomm       Date:  2019-01-11       Impact factor: 3.597

10.  Increased expression of EphA1 protein in prostate cancers correlates with high Gleason score.

Authors:  Libo Peng; Haiyan Wang; Yingchun Dong; Jie Ma; Juanjuan Wen; Jinrong Wu; Xueqing Wang; Xiaojun Zhou; Jiandong Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.